• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Friday

    1/7/22 10:39:09 AM ET
    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Aerospace
    Industrials
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $ACHR alert in real time by email

     

    Before 10 am on Friday, 110 companies set new 52-week lows.

    Interesting Points From Today's 52-Week Lows:

    • Humana (NYSE:HUM) was the biggest company on a market cap basis to set a new 52-week low.
    • Reshape Lifesciences (NASDAQ:RSLS) was the smallest firm on a market cap basis to set a new 52-week low.
    • Aligos Therapeutics (NASDAQ:ALGS)'s stock moved significantly downwards, trading down 46.75% to reach a new 52-week low.
    • Athenex (NASDAQ:ATNX) shares were the most resilient of the group, as shares actually moved up 0.0% in response to hitting its 52-week low.

    Stocks that set new 52-week lows during the first half-hour of trading on Friday are as follows:

    • Humana (NYSE:HUM) stock hit $352.38 on Friday morning, setting a new 52-week low for a change of down 3.19%.
    • CoStar Gr (NASDAQ:CSGP) stock dropped to a yearly low on Friday of $72.91. Shares traded down 0.99%.
    • Roku (NASDAQ:ROKU) stock hit a new 52-week low of $180.49. The stock was down 3.79% on the session.
    • DiDi Global (NYSE:DIDI) shares made a new 52-week low of $4.56 on Friday. The stock was down 1.49% for the day.
    • Chewy (NYSE:CHWY) stock hit a new 52-week low of $48.61. The stock was down 6.24% on the session.
    • Elanco Animal Health (NYSE:ELAN) stock broke to a new 52-week low of $26.86 on Friday. Shares of the company traded up 0.92%.
    • Cognex (NASDAQ:CGNX) shares fell to $71.38 on Friday, setting a new 52-week low with a shift of down 1.46%.
    • Aurora Innovation (NASDAQ:AUR) stock broke to a new 52-week low of $9.05 on Friday. Shares of the company traded down 3.55%.
    • Natera (NASDAQ:NTRA) stock achieved a new 52-week low on Friday morning, hitting $80.02 and moving down 1.84%.
    • Oak Street Health (NYSE:OSH) shares were down 2.95% for the day, having made a 52-week low of $25.63.
    • Cazoo Gr (NYSE:CZOO) shares fell to $4.80 on Friday, setting a new 52-week low with a shift of down 0.6%.
    • Embark Technology (NASDAQ:EMBK) stock broke to a new 52-week low of $6.50 on Friday. Shares of the company traded down 1.69%.
    • Sendas Distribuidora (NYSE:ASAI) shares set a new 52-week low of $10.01. The stock traded down 1.37%.
    • Expensify (NASDAQ:EXFY) stock broke to a new 52-week low of $31.50 on Friday. Shares of the company traded down 5.12%.
    • Open Lending (NASDAQ:LPRO) shares set a new yearly low of $19.90 this morning. The stock was up 0.15% on the session.
    • Alignment Healthcare (NASDAQ:ALHC) shares reached a new 52-week low of $11.21 on Friday morning, moving down 1.53%.
    • Udemy (NASDAQ:UDMY) stock hit a new 52-week low of $14.47. The stock was down 2.2% on the session.
    • Mirion Technologies (NYSE:MIR) shares made a new 52-week low of $9.47 on Friday. The stock was down 2.54% for the day.
    • N-able (NYSE:NABL) stock hit $10.29 on Friday morning, setting a new 52-week low for a change of down 0.77%.
    • Clover Health Investments (NASDAQ:CLOV) stock hit a new 52-week low of $3.19. The stock was down 2.44% on the session.
    • Cano Health (NYSE:CANO) stock dropped to a yearly low on Friday of $7.82. Shares traded down 2.93%.
    • Nuvation Bio (NYSE:NUVB) shares moved down 2.23% on Friday to hit a new 52-week low of $6.45, drifting down 2.23%.
    • Doma Holdings (NYSE:DOMA) shares set a new yearly low of $4.28 this morning. The stock was up 0.46% on the session.
    • Silk Road Medical (NASDAQ:SILK) shares fell to $37.91 on Friday, setting a new 52-week low with a shift of up 1.6%.
    • Sharecare (NASDAQ:SHCR) shares reached a new 52-week low of $3.91 on Friday morning, moving down 4.36%.
    • Heliogen (NYSE:HLGN) stock dropped to a yearly low on Friday of $6.95. Shares traded down 10.47%.
    • Velo3D (NYSE:VLD) shares were down 1.98% for the day, having made a 52-week low of $6.32.
    • Archer Aviation (NYSE:ACHR) shares set a new 52-week low of $4.62. The stock traded down 7.24%.
    • Vicarious Surgical (NYSE:RBOT) stock achieved a new 52-week low on Friday morning, hitting $9.11 and moving down 0.22%.
    • Companhia Brasileira (NYSE:CBD) stock achieved a new 52-week low on Friday morning, hitting $3.42 and moving down 0.29%.
    • CEVA (NASDAQ:CEVA) shares were down 1.5% for the day, having made a 52-week low of $39.77.
    • Telos (NASDAQ:TLS) shares set a new 52-week low of $13.54. The stock traded down 1.51%.
    • GoHealth (NASDAQ:GOCO) shares moved down 4.72% on Friday to hit a new 52-week low of $2.58, drifting down 4.72%.
    • PMV Pharmaceuticals (NASDAQ:PMVP) stock set a new 52-week low of $18.33 on Friday, moving down 0.42%.
    • Repare Therapeutics (NASDAQ:RPTX) stock set a new 52-week low of $17.63 on Friday, moving down 4.23%.
    • Cardiovascular Systems (NASDAQ:CSII) stock hit a new 52-week low of $18.27. The stock was down 2.03% on the session.
    • Meta Materials (NASDAQ:MMAT) shares made a new 52-week low of $2.41 on Friday. The stock was up 0.2% for the day.
    • Berkeley Lights (NASDAQ:BLI) shares were up 2.83% for the day, having made a 52-week low of $9.40.
    • Nuvalent (NASDAQ:NUVL) shares hit a yearly low of $13.91. The stock was down 4.98% on the session.
    • Kinnate Biopharma (NASDAQ:KNTE) stock dropped to a yearly low on Friday of $14.74. Shares traded down 3.29%.
    • Nano X Imaging (NASDAQ:NNOX) stock broke to a new 52-week low of $13.31 on Friday. Shares of the company traded down 0.44%.
    • 908 Devices (NASDAQ:MASS) shares moved down 0.44% on Friday to hit a new 52-week low of $20.05, drifting down 0.44%.
    • BioAtla (NASDAQ:BCAB) shares were down 0.16% for the day, having made a 52-week low of $15.43.
    • Decarbonization Plus (NASDAQ:DCRN) stock hit a yearly low of $9.38. The stock was down 0.41% for the day.
    • OraSure Technologies (NASDAQ:OSUR) stock drifted down 1.78% on Friday morning to hit a new 52-week low of $7.61.
    • Phathom Pharmaceuticals (NASDAQ:PHAT) stock drifted up 0.4% on Friday morning to hit a new 52-week low of $17.25.
    • SkyWater Technology (NASDAQ:SKYT) shares made a new 52-week low of $13.03 on Friday. The stock was down 1.04% for the day.
    • Vuzix (NASDAQ:VUZI) stock hit a yearly low of $7.97. The stock was down 1.7% for the day.
    • Hyperfine (NASDAQ:HYPR) shares set a new yearly low of $6.80 this morning. The stock was down 2.86% on the session.
    • BlackSky Technology (NYSE:BKSY) stock drifted up 1.95% on Friday morning to hit a new 52-week low of $3.87.
    • Entrada Therapeutics (NASDAQ:TRDA) shares made a new 52-week low of $11.86 on Friday. The stock was down 5.71% for the day.
    • Shattuck Labs (NASDAQ:STTK) shares moved down 1.19% on Friday to hit a new 52-week low of $7.41, drifting down 1.19%.
    • Esperion Therapeutics (NASDAQ:ESPR) stock drifted up 0.34% on Friday morning to hit a new 52-week low of $4.29.
    • 111 (NASDAQ:YI) shares set a new 52-week low of $2.99. The stock traded up 1.32%.
    • Fluidigm (NASDAQ:FLDM) stock dropped to a yearly low on Friday of $3.21. Shares traded up 0.77%.
    • RxSight (NASDAQ:RXST) stock broke to a new 52-week low of $9.13 on Friday. Shares of the company traded down 1.62%.
    • Luna Innovations (NASDAQ:LUNA) stock hit a yearly low of $7.63. The stock was up 0.45% for the day.
    • CalAmp (NASDAQ:CAMP) shares moved down 1.37% on Friday to hit a new 52-week low of $6.69, drifting down 1.37%.
    • Aligos Therapeutics (NASDAQ:ALGS) shares fell to $4.15 on Friday, setting a new 52-week low with a shift of down 46.75%.
    • ChromaDex (NASDAQ:CDXC) shares set a new yearly low of $3.38 this morning. The stock was down 1.16% on the session.
    • Mogo (NASDAQ:MOGO) shares hit a yearly low of $2.97. The stock was down 0.33% on the session.
    • Humanigen (NASDAQ:HGEN) stock achieved a new 52-week low on Friday morning, hitting $3.06 and moving up 0.8%.
    • Cascadia Acquisition (NASDAQ:CCAI) shares fell to $9.66 on Friday, setting a new 52-week low with a shift of down 0.31%.
    • Helbiz (NASDAQ:HLBZ) shares made a new 52-week low of $5.28 on Friday. The stock was down 0.79% for the day.
    • Beam Global (NASDAQ:BEEM) stock hit a new 52-week low of $16.06. The stock was down 1.08% on the session.
    • Shapeways Hldgs (NYSE:SHPW) stock set a new 52-week low of $3.01 on Friday, moving down 0.66%.
    • Athenex (NASDAQ:ATNX) stock broke to a new 52-week low of $1.30 on Friday. Shares of the company traded 0.0% (flat).
    • Field Trip Health (NASDAQ:FTRP) stock hit a new 52-week low of $2.07. The stock was up 1.96% on the session.
    • O2Micro Intl (NASDAQ:OIIM) shares moved down 0.67% on Friday to hit a new 52-week low of $4.25, drifting down 0.67%.
    • SOC Telemed (NASDAQ:TLMD) stock achieved a new 52-week low on Friday morning, hitting $1.15 and moving down 3.23%.
    • Avalo Therapeutics (NASDAQ:AVTX) stock hit a new 52-week low of $0.98. The stock was down 14.88% on the session.
    • Mullen Automotive (NASDAQ:MULN) shares moved down 1.4% on Friday to hit a new 52-week low of $4.78, drifting down 1.4%.
    • 4d pharma (NASDAQ:LBPS) stock hit $5.01 on Friday morning, setting a new 52-week low for a change of down 4.8%.
    • Aurora Mobile (NASDAQ:JG) stock hit a yearly low of $0.92. The stock was down 3.67% for the day.
    • Applied Therapeutics (NASDAQ:APLT) shares were down 1.62% for the day, having made a 52-week low of $4.20.
    • Ayala Pharmaceuticals (NASDAQ:AYLA) shares hit a yearly low of $7.50. The stock was down 1.9% on the session.
    • Neuronetics (NASDAQ:STIM) stock achieved a new 52-week low on Friday morning, hitting $3.69 and moving down 3.33%.
    • DTFTax-Free Income (NYSE:DTF) shares set a new 52-week low of $14.08. The stock traded down 0.18%.
    • Anixa Biosciences (NASDAQ:ANIX) shares reached a new 52-week low of $2.71 on Friday morning, moving up 3.77%.
    • Ontrak (NASDAQ:OTRK) shares set a new 52-week low of $4.54. The stock traded down 3.15%.
    • Clever Leaves Holdings (NASDAQ:CLVR) stock set a new 52-week low of $2.72 on Friday, moving up 1.45%.
    • Cidara Therapeutics (NASDAQ:CDTX) stock hit $1.06 on Friday morning, setting a new 52-week low for a change of down 4.34%.
    • iSun (NASDAQ:ISUN) stock drifted down 2.14% on Friday morning to hit a new 52-week low of $5.26.
    • Freeline Therapeutics (NASDAQ:FRLN) stock hit a yearly low of $1.71. The stock was down 9.61% for the day.
    • MamaMancini's Holdings (NASDAQ:MMMB) stock dropped to a yearly low on Friday of $1.77. Shares traded down 2.54%.
    • Cocrystal Pharma (NASDAQ:COCP) shares set a new yearly low of $0.59 this morning. The stock was down 4.78% on the session.
    • Imara (NASDAQ:IMRA) shares set a new 52-week low of $2.08. The stock traded down 0.47%.
    • Odonate Therapeutics (NASDAQ:ODT) stock hit a yearly low of $0.85. The stock was down 1.65% for the day.
    • TD Hldgs (NASDAQ:GLG) stock hit a new 52-week low of $0.35. The stock was down 2.07% on the session.
    • E-Home Household Service (NASDAQ:EJH) shares set a new yearly low of $1.27 this morning. The stock was down 0.77% on the session.
    • Clarus Therapeutics Hldgs (NASDAQ:CRXT) stock set a new 52-week low of $1.68 on Friday, moving down 2.79%.
    • Recon Technology (NASDAQ:RCON) shares made a new 52-week low of $1.24 on Friday. The stock was up 3.87% for the day.
    • Enveric Biosciences (NASDAQ:ENVB) stock drifted up 0.6% on Friday morning to hit a new 52-week low of $0.83.
    • Catalyst Biosciences (NASDAQ:CBIO) stock achieved a new 52-week low on Friday morning, hitting $0.84 and moving up 0.16%.
    • Metacrine (NASDAQ:MTCR) stock hit a new 52-week low of $0.57. The stock was up 2.87% on the session.
    • Cuentas (NASDAQ:CUEN) stock achieved a new 52-week low on Friday morning, hitting $1.23 and moving up 0.79%.
    • Siyata Mobile (NASDAQ:SYTA) stock set a new 52-week low of $1.78 on Friday, moving down 43.96%.
    •  

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ACHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHR
    $ALGS
    $ALHC
    $ANIX

    CompanyDatePrice TargetRatingAnalyst
    CEVA Inc.
    $CEVA
    2/25/2026$27.00Buy
    UBS
    CoStar Group Inc.
    $CSGP
    2/20/2026$67.00Hold → Buy
    Jefferies
    N-able Inc.
    $NABL
    2/20/2026$9.50 → $5.50Market Perform
    BMO Capital Markets
    Chewy Inc.
    $CHWY
    2/19/2026$28.00Mkt Perform → Outperform
    Raymond James
    Cognex Corporation
    $CGNX
    2/17/2026$68.00Hold → Buy
    HSBC Securities
    Roku Inc.
    $ROKU
    2/13/2026$118.00Neutral → Buy
    Rosenblatt
    Humana Inc.
    $HUM
    2/12/2026$189.00Outperform → Sector Perform
    RBC Capital Mkts
    Entrada Therapeutics Inc.
    $TRDA
    2/11/2026$20.00Buy
    Guggenheim
    More analyst ratings

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Frost Phillip Md Et Al bought $19,952 worth of shares (20,000 units at $1.00) (SEC Form 4)

    4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)

    2/25/26 4:10:11 PM ET
    $COCP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President, CenterWell Shetty Sanjay K bought $150,016 worth of Humana Common (810 units at $185.21), increasing direct ownership by 7% to 11,657 units (SEC Form 4)

    4 - HUMANA INC (0000049071) (Issuer)

    2/25/26 11:48:38 AM ET
    $HUM
    Medical Specialities
    Health Care

    Director Liu Jaclyn bought $25,086 worth of shares (1,310 units at $19.15), increasing direct ownership by 4% to 32,470 units (SEC Form 4)

    4 - CEVA INC (0001173489) (Issuer)

    2/23/26 4:10:10 PM ET
    $CEVA
    Computer Software: Programming Data Processing
    Technology

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VOQUEZNA issued to PHATHOM PHARMACEUTICALS INC

    Submission status for PHATHOM PHARMACEUTICALS INC's drug VOQUEZNA (ORIG-1) with active ingredient VONOPRAZAN FUMARATE has changed to 'Approval' on 07/17/2024. Application Category: NDA, Application Number: 218710, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    7/18/24 10:52:01 AM ET
    $PHAT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-16) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:30 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-17) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:37 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS initiated coverage on Ceva with a new price target

    UBS initiated coverage of Ceva with a rating of Buy and set a new price target of $27.00

    2/25/26 7:50:00 AM ET
    $CEVA
    Computer Software: Programming Data Processing
    Technology

    CoStar Group upgraded by Jefferies with a new price target

    Jefferies upgraded CoStar Group from Hold to Buy and set a new price target of $67.00

    2/20/26 8:19:35 AM ET
    $CSGP
    Real Estate

    BMO Capital Markets reiterated coverage on N-able with a new price target

    BMO Capital Markets reiterated coverage of N-able with a rating of Market Perform and set a new price target of $5.50 from $9.50 previously

    2/20/26 7:58:12 AM ET
    $NABL
    Computer Software: Prepackaged Software
    Technology

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    SEC Filings

    View All

    SEC Form 10-K filed by CEVA Inc.

    10-K - CEVA INC (0001173489) (Filer)

    2/27/26 4:03:13 PM ET
    $CEVA
    Computer Software: Programming Data Processing
    Technology

    SEC Form 10-K filed by Clover Health Investments Corp.

    10-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)

    2/27/26 8:08:29 AM ET
    $CLOV
    Medical Specialities
    Health Care

    SEC Form EFFECT filed by RxSight Inc.

    EFFECT - RxSight, Inc. (0001111485) (Filer)

    2/27/26 12:15:07 AM ET
    $RXST
    Ophthalmic Goods
    Health Care

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Vuzix Schedules Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results and Business Update

    ROCHESTER, N.Y., Feb. 27, 2026 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of smart glasses and Augmented Reality (AR) technology and products, is pleased to announce that the Company will host a conference call regarding its fourth quarter and full year 2025 operating results on Thursday, March 12, 2026 at 4:30 PM Eastern Time (ET). To join the live conference call, please dial 877-709-8150 (U.S. and Canadian callers) or 201-689-8354 (international callers outside of the U.S. and Canada) 10 to 15 minutes prior to the schedul

    2/27/26 3:00:00 PM ET
    $VUZI
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Signatera™ MRD Data at ASCO GU Highlights Potential Utility Across GU Cancers, Including for Bladder Preservation

    11 scientific abstracts, including 4 oral presentations and a concurrent publication in Nature Medicine, underscore how Signatera MRD can improve quality of life for patients with genitourinary cancers Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, today announced it will present new data in genitourinary malignancies at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), taking place February 26-28, 2026. Across four oral presentations in muscle-invasive bladder cancer (MIBC), these data reinforce Signatera's role in identifying patients who benefit from adjuvant immunotherapy, supporting response-adaptive bladder p

    2/27/26 10:05:00 AM ET
    $NTRA
    Medical Specialities
    Health Care

    Industry-First: Archer to Bring Starlink Onboard Midnight Air Taxis

      Archer Aviation Inc. (NYSE:ACHR) today announced it will work with Starlink to bring stable, reliable and high-speed connectivity to its air taxis, marking Starlink's entry into the emerging air mobility category and an industry-first collaboration. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227452874/en/Archer's Midnight aircraft at its facilities in Hawthorne, CA Under the agreement, Archer will install Starlink's low-Earth-orbit (LEO) satellite internet system into its Midnight aircraft and conduct testing. The system is designed to provide high-speed, low-latency, connectivity during Midnight's air taxi operations

    2/27/26 8:30:00 AM ET
    $ACHR
    Aerospace
    Industrials

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief People Officer Pai Kathleen was granted 80,000 shares, increasing direct ownership by 15% to 624,097 units (SEC Form 4)

    4 - N-able, Inc. (0001834488) (Issuer)

    2/27/26 4:09:52 PM ET
    $NABL
    Computer Software: Prepackaged Software
    Technology

    EVP, CTPO Adler Michael I was granted 110,000 shares, increasing direct ownership by 22% to 609,983 units (SEC Form 4)

    4 - N-able, Inc. (0001834488) (Issuer)

    2/27/26 4:08:20 PM ET
    $NABL
    Computer Software: Prepackaged Software
    Technology

    EVP, GC, Secretary Anastos Peter C was granted 72,500 shares, increasing direct ownership by 18% to 464,462 units (SEC Form 4)

    4 - N-able, Inc. (0001834488) (Issuer)

    2/27/26 4:08:54 PM ET
    $NABL
    Computer Software: Prepackaged Software
    Technology

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Leadership Updates

    Live Leadership Updates

    View All

    Chewy Appoints Chris Deppe as Chief Financial Officer

    Chewy, Inc. (NYSE:CHWY) ("Chewy"), a leading and trusted destination for pet parents and partners everywhere, announced today the appointment of Chris Deppe as Chief Financial Officer (CFO). Deppe is a seasoned finance and operations leader with more than 20 years of experience. He joined Chewy in 2022 as the Vice President of Supply Chain and Operations Finance, and most recently served as the Head of all Corporate and Commercial Finance Functions. During his tenure, he has played a key role in advancing the company's financial strategy, enhancing operational rigor, and supporting strong business performance aligned with Chewy's long-term strategic priorities. Prior to joining Chewy, D

    2/24/26 9:00:00 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    Diality Appoints Peter Donato as Chief Financial Officer

    Life sciences veteran brings private and public sector expertise to company in midst of growth trajectory Diality Inc., a medical device company that has developed the Moda-flx™ Hemodialysis System, today announced it has named Peter Donato as its chief financial officer. Donato joins the company as it continues to enroll patients in the PRESCRIBE Diality Home Hemodialysis Clinical Trial of its Moda-flx Hemodialysis System while preparing for a limited market release in 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224064413/en/Diality CFO Peter Donato. Donato joins Diality with nearly 35 years of financial leadershi

    2/24/26 7:05:00 AM ET
    $MYGN
    $STIM
    $TFX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care
    Medical/Dental Instruments
    Pharmaceuticals and Biotechnology

    Cognex Appoints Sami Atiya and Chris Donato to Board of Directors

    NATICK, Mass., Feb. 17, 2026 /PRNewswire/ -- Cognex Corporation (NASDAQ:CGNX), ("Cognex"), the global technology leader in industrial machine vision, today announced the appointments of Dr. Sami Atiya and Mr. Chris Donato to Cognex's Board of Directors (the "Board"), effective March 2, 2026.  "We are excited to welcome Sami and Chris to our Board," said Matt Moschner, President and CEO. "We remain focused on our strategic objectives of becoming the leading provider of AI technology for industrial machine vision, delivering the best customer experience in our industry and doublin

    2/17/26 8:00:00 AM ET
    $CGNX
    Industrial Machinery/Components
    Industrials

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Financial Insight: Purchase at Clover Health Investments Corp. on Jun 20

    The recent insider purchase at Clover Health Investments Corp. by Director Garipalli Vivek on June 20, 2024, has caught the attention of investors. Director Garipalli Vivek bought $1,000,426 worth of shares, acquiring 877,567 units at $1.14 per share, as reported in SEC Form 4. This insider purchase stands out among recent insider transactions at Clover Health. Looking at the previous transactions, there have been instances of insiders covering exercise/tax liability by selling shares, resulting in a decrease in their direct ownership percentages. For example, Reynoso Jamie L., Priest Brady Patrick, Toy Andrew, Sharp Aric R, Soares Karen, Chief Technology Officer Wai Conrad, and CEO Reynoso

    6/20/24 6:36:05 PM ET
    $CLOV
    Medical Specialities
    Health Care

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Financials

    Live finance-specific insights

    View All

    Vuzix Schedules Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results and Business Update

    ROCHESTER, N.Y., Feb. 27, 2026 /PRNewswire/ -- Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of smart glasses and Augmented Reality (AR) technology and products, is pleased to announce that the Company will host a conference call regarding its fourth quarter and full year 2025 operating results on Thursday, March 12, 2026 at 4:30 PM Eastern Time (ET). To join the live conference call, please dial 877-709-8150 (U.S. and Canadian callers) or 201-689-8354 (international callers outside of the U.S. and Canada) 10 to 15 minutes prior to the schedul

    2/27/26 3:00:00 PM ET
    $VUZI
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Bitwise Announces Monthly Distributions for IMST, ICOI, IMRA, IGME, ICRC, and IETH

    SAN FRANCISCO, Feb. 26, 2026 /PRNewswire/ -- Bitwise Asset Management, a leading crypto asset manager, today announced the monthly distributions for its suite of Option Income Strategy ETFs: IMST, ICOI, IMRA, IGME, ICRC, and IETH. FundTickerDistribution Per ShareDistribution Rate30-Day SEC YieldReturn of CapitalEx-Date / Record DatePayment Date1-Month Return1-Year ReturnSince InceptionReturnBitwise COINOption Income Strategy ETFICOI$0.6149255.74 %0.00 %100.00 %02/27/202603/03/2026-12.65 %N/A-25.29 %Bitwise MARAOption Income Strategy ETFIMRA$0.3058725.67 %0.00 %100.00 %02/27/2026

    2/26/26 4:22:00 PM ET
    $IMRA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance

    Business Highlights: Generated full year 2025 Adjusted EBITDA profitability while growing membership by 38% and Insurance revenue by 41% year-over-yearAchieved industry-leading 2026 AEP growth of 53% year-over-year with strong returning member retentionExpect improving cohort economics powered by Clover Assistant to drive our first-ever full year of GAAP Net Income profitability in 2026 Financial Results: Full year 2025 Medicare Advantage membership of 113,803, up 38% year-over-yearFull year 2025 Total revenues of $1.9 billion, up 40% year-over-yearFull year 2025 GAAP Net loss of $86 million, Adjusted EBITDA of $22 million, and Adjusted Net Income of $20 million Full Year 2026 Gu

    2/26/26 4:05:00 PM ET
    $CLOV
    Medical Specialities
    Health Care

    $ACHR
    $ALGS
    $ALHC
    $ANIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Neuronetics Inc.

    SC 13D - Neuronetics, Inc. (0001227636) (Subject)

    12/17/24 9:15:11 PM ET
    $STIM
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by PMV Pharmaceuticals Inc.

    SC 13G - PMV Pharmaceuticals, Inc. (0001699382) (Subject)

    12/12/24 12:29:41 PM ET
    $PMVP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Cidara Therapeutics Inc.

    SC 13G - Cidara Therapeutics, Inc. (0001610618) (Subject)

    12/9/24 5:37:15 PM ET
    $CDTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care